http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-862588-L
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D457-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D457-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-48 |
filingDate | 1986-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1987-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | IE-862588-L |
titleOfInvention | Dihydrolysergate esters |
abstract | Compounds of the formula <CHEM> wherein R is primary or secondary C1-C8 alkyl, C2-C4 alkenyl-CH2, C3-C8 cycloalkyl or C3-C6 cycloalkyl-substituted C1-C5 primary or secondary alkyl, the total number of carbon atoms in R not to exceed 8; R<1> is allyl, H, or C1-C4 straight chain alkyl, and R<2> is C1-C3 alkoxy-C5-C7 cycloalkyl; a primary or secondary C1-C3 alkoxy-C2-C6-alkyl or di(C1-C3 alkoxy)-C2-C6alkyl; C3-C7 ketoalkyl; or C5-C7 cycloalkyl or keto-substituted C5-C7 cycloalkyl; or 4-hydroxycyclohexyl; or a pharmaceutically-acceptable salt thereof, are useful as 5HT2 receptor antagonists.n[EP0219257A2] |
priorityDate | 1985-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 117.